1-(2-Bromo-6-fluorophenyl)-N-methylmethanamine, 98%, 250mg

Esperidina, ≥ 90%, 25 g, confezione in plastica.

(2S,3S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-ethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 100mg

4-Bromo-N-phenylbenzamide, 98%, 5g

5,10,15,20-Tetraphenyl-21H,23H-porphine copper(II), 98%, 5g

5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 10g

[2,2'-Bipyridine]-6,6'-dicarbonitrile, 95.0%, 5g

2-Iodo-5-methylaniline, 98.0%, 500g

(S)-tert-Butyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate, 95.0%, 10g

Ethyl 2-(trifluoromethyl)pyrimidine-5-carboxylate, 95.0%, 5g

6-Methoxytryptamine>98.0%(HPLC)(T)500mg

2,3,6-TRIFLUORO-5-NITROBENZOIC ACID, 95.0%, 500mg

Diethyl Propylmalonate>98.0%(GC)5mL